With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Today, Remedy Place is selling injectable NAD+ Smart Pens that customers can use at home in just seconds. Here's what makes them different from an IV.

Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and rapidly commoditising pricing dynamics.

Paris will choose a new mayor on Sunday, with one unlikely issue dominating campaigns alongside all the partisan acrimony - dogs. Candidates from socialists to conservatives have set out policies to ...